Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Giorgio Aquila, Aleksandra Kostina, Francesco Vieceli Dalla Sega, Eugeniy Shlyakhto, Anna Kostareva, Luisa Marracino, Roberto Ferrari, Paola Rizzo & Anna Malaschicheva. (2019) The Notch pathway: a novel therapeutic target for cardiovascular diseases?. Expert Opinion on Therapeutic Targets 23:8, pages 695-710.
Read now
Read now
Brian D. Adams, Christine Parsons & Frank J. Slack. (2016) The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas. Expert Opinion on Therapeutic Targets 20:6, pages 737-753.
Read now
Read now
Articles from other publishers (38)
Anna Wójtowicz, Tomasz Molcan, Karolina Lukasik, Ewelina Żebrowska, Klaudia Pawlina-Tyszko, Artur Gurgul, Tomasz Szmatoła, Monika Bugno-Poniewierska, Graca Ferreira-Dias, Dariusz J. Skarzynski & Anna Szóstek-Mioduchowska. (2023) The potential role of miRNAs and regulation of their expression in the development of mare endometrial fibrosis. Scientific Reports 13:1.
Crossref
Crossref
Laura Zapata-Martínez, Sonia Águila, Ascensión M. de los Reyes-García, Salvador Carrillo-Tornel, María L. Lozano, Rocío González-Conejero & Constantino Martínez. (2023) Inflammatory microRNAs in cardiovascular pathology: another brick in the wall. Frontiers in Immunology 14.
Crossref
Crossref
Suguru Saito, Shin-ichiro Ohno, Yuichirou Harada, Yoshihiko Kanno & Masahiko Kuroda. (2023) MiR-34a induces myofibroblast differentiation from renal fibroblasts. Clinical and Experimental Nephrology 27:5, pages 411-418.
Crossref
Crossref
Tingting Li, Zhipeng Yan, Yajie Fan, Xinbiao Fan, Aolin Li, Zhongwen Qi & Junping Zhang. (2023) Cardiac repair after myocardial infarction: A two-sided role of inflammation-mediated. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
A.M. Alieva, E.V. Reznik, N.V. Teplova, A.A. Melikulov, M.F. Akhmedova, I.A. Kotikova & I.G. Nikitin. (2023) MicroRNA-34a in cardiovascular disease: a glimpse into the future. Kardiologicheskii vestnik 18:1, pages 14.
Crossref
Crossref
Bianca C. Bernardo, Gunes S. Yildiz, Helen Kiriazis, Claudia A. Harmawan, Celeste M. K. Tai, Rebecca H. Ritchie & Julie R. McMullen. (2022) In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function. Cells 11:19, pages 3117.
Crossref
Crossref
Hongyi Chen, Luocheng Lv, Ruoxu Liang, Weimin Guo, Zhaofu Liao, Yilin Chen, Kuikui Zhu, Ruijin Huang, Hui Zhao, Qin Pu, Ziqiang Yuan, Zhaohua Zeng, Xin Zheng, Shanshan Feng, Xufeng Qi & Dongqing Cai. (2022)
miR
‐486 improves fibrotic activity in myocardial infarction by targeting
SRSF3
/
p21‐Mediated
cardiac myofibroblast senescence
. Journal of Cellular and Molecular Medicine 26:20, pages 5135-5149.
Crossref
Crossref
Yuanyuan Zhao, Dunfeng Du, Shanshan Chen, Zhishui Chen & Jiajia Zhao. (2022) New Insights into the Functions of MicroRNAs in Cardiac Fibrosis: From Mechanisms to Therapeutic Strategies. Genes 13:8, pages 1390.
Crossref
Crossref
Min Zhao, Qin Qi, Shimin Liu, Rong Huang, Jiacheng Shen, Yi Zhu, Jing Chai, Handan Zheng, Huangan Wu & Huirong Liu. (2022) MicroRNA-34a: A Novel Therapeutic Target in Fibrosis. Frontiers in Physiology 13.
Crossref
Crossref
Chunzhen Ren, Kai Liu, Xinke Zhao, Huan Guo, Yali Luo, Juan Chang, Xiang Gao, Xinfang Lv, Xiaodong Zhi, Xue Wu, Hugang Jiang, Qilin Chen & Yingdong Li. (2022) Research Progress of Traditional Chinese Medicine in Treatment of Myocardial fibrosis. Frontiers in Pharmacology 13.
Crossref
Crossref
Fahimeh Varzideh, Urna Kansakar, Kwame Donkor, Scott Wilson, Stanislovas S. Jankauskas, Pasquale Mone, Xujun Wang, Angela Lombardi & Gaetano Santulli. (2022) Cardiac Remodeling After Myocardial Infarction: Functional Contribution of microRNAs to Inflammation and Fibrosis. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Cun-Cun Hua, Xin-Ming Liu, Li-Rong Liang, Le-Feng Wang & Jiu-Chang Zhong. (2022) Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
Angela Raucci, Federica Macrì, Stefania Castiglione, Ileana Badi, Maria Cristina Vinci & Estella Zuccolo. (2021) MicroRNA-34a: the bad guy in age-related vascular diseases. Cellular and Molecular Life Sciences 78:23, pages 7355-7378.
Crossref
Crossref
Yuquan Zhang, Shuzhu Liu, Limin Ding, Dawei Wang, Qiangqiang Li & Dongdong Li. (2021) Circ_0030235 knockdown protects H9c2 cells against OGD/R-induced injury via regulation of miR-526b. PeerJ 9, pages e11482.
Crossref
Crossref
Liana Maries, Cătălin Marian, Raluca Sosdean, Flavia Goanta, Ioan Ovidiu Sirbu & Andrei Anghel. (2021) MicroRNAs—The Heart of Post-Myocardial Infarction Remodeling. Diagnostics 11:9, pages 1675.
Crossref
Crossref
Debarati Roychowdhury, Samir Gupta, Xihan Qin, Cecilia N Arighi & K Vijay-Shanker. (2021) emiRIT: a text-mining-based resource for microRNA information. Database 2021.
Crossref
Crossref
Michaela Adamcova, Ippei Kawano & Fedor Simko. (2021) The Impact of microRNAs in Renin–Angiotensin-System-Induced Cardiac Remodelling. International Journal of Molecular Sciences 22:9, pages 4762.
Crossref
Crossref
Ying Pan, Jing Wang, Lan He & Fengchun Zhang. (2021) MicroRNA-34a Promotes EMT and Liver Fibrosis in Primary Biliary Cholangitis by Regulating TGF-β1/smad Pathway. Journal of Immunology Research 2021, pages 1-13.
Crossref
Crossref
Sara Panizo, Laura Martínez-Arias, Cristina Alonso-Montes, Pablo Cannata, Beatriz Martín-Carro, José L. Fernández-Martín, Manuel Naves-Díaz, Natalia Carrillo-López & Jorge B. Cannata-Andía. (2021) Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences. International Journal of Molecular Sciences 22:1, pages 408.
Crossref
Crossref
Paul HolvoetPaul Holvoet. 2021. Non-coding RNAs at the Cross-Road of Cardiometabolic Diseases and Cancer. Non-coding RNAs at the Cross-Road of Cardiometabolic Diseases and Cancer
119
147
.
Fatemeh Yousefi, Zahra Shabaninejad, Sina Vakili, Maryam Derakhshan, Ahmad Movahedpour, Hamed Dabiri, Younes Ghasemi, Maryam Mahjoubin-Tehran, Azin Nikoozadeh, Amir Savardashtaki, Hamed Mirzaei & Michael R. Hamblin. (2020) TGF-β and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus. Cell Communication and Signaling 18:1.
Crossref
Crossref
Zhiqian WangMingming FuYongjun Li. (2020) miR-142-5p and miR-212-5p cooperatively inhibit the proliferation and collagen formation of cardiac fibroblasts by regulating c-Myc/TP53INP1. Canadian Journal of Physiology and Pharmacology 98:5, pages 314-323.
Crossref
Crossref
Holly E. Kinser & Zachary Pincus. (2019) MicroRNAs as modulators of longevity and the aging process. Human Genetics 139:3, pages 291-308.
Crossref
Crossref
Marcelo B. Cavalcante, Tatiana D. Saccon, Allancer D.C. Nunes, James L. Kirkland, Tamara Tchkonia, Augusto Schneider & Michal M. Masternak. (2020) Dasatinib plus quercetin prevents uterine age-related dysfunction and fibrosis in mice. Aging 12:3, pages 2711-2722.
Crossref
Crossref
Prabhat Ranjan, Rajesh Kumari & Suresh Kumar Verma. (2019) Cardiac Fibroblasts and Cardiac Fibrosis: Precise Role of Exosomes. Frontiers in Cell and Developmental Biology 7.
Crossref
Crossref
Ryan WangJustin LinRushita A. Bagchi. (2019) Novel molecular therapeutic targets in cardiac fibrosis: a brief overview. Canadian Journal of Physiology and Pharmacology 97:4, pages 246-256.
Crossref
Crossref
Yao Zhang, Yuan Lu, Machuki Jeremiah Ong’achwa, Liqi Ge, Yun Qian, Lei Chen, Xiaoqin Hu, Fei Li, Hui Wei, Chaoqun Zhang, Chengzong Li & Zhirong Wang. (2018)
Resveratrol Inhibits the TGF-
β
1-Induced Proliferation of Cardiac Fibroblasts and Collagen Secretion by Downregulating miR-17 in Rat
. BioMed Research International 2018, pages 1-10.
Crossref
Crossref
Ning Li, Heng Zhou & Qizhu Tang. (2018) miR-133: A Suppressor of Cardiac Remodeling?. Frontiers in Pharmacology 9.
Crossref
Crossref
Haiou Pan, Yan Li, Haifeng Qian, Xiguang Qi, Gangcheng Wu, Hui Zhang, Meijuan Xu, Zhiming Rao, Jin-long Li, Li Wang & Hao Ying. (2018) Effects of Geniposide from Gardenia Fruit Pomace on Skeletal-Muscle Fibrosis. Journal of Agricultural and Food Chemistry 66:23, pages 5802-5811.
Crossref
Crossref
Haifeng ShaoLili YangLi WangBozan TangJian WangQiang Li. (2018) MicroRNA-34a protects myocardial cells against ischemia–reperfusion injury through inhibiting autophagy via regulating TNFα expression. Biochemistry and Cell Biology 96:3, pages 349-354.
Crossref
Crossref
T. G. Starchenko, S. N. Koval, K. A. Yushko, V. L. Shkapo & D. K. Miloslavsky. (2018) FORMATION OF HEART RHYTHM DISTURBANCES IN PATIENTS WITH ESSENTIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS. Bulletin of Problems Biology and Medicine 1:2, pages 42.
Crossref
Crossref
Pia Klausen, John Gásdal Karstensen, Mehmet Coskun, Adrian Săftoiu, Peter Vilmann, Jack Bernard Cowland & Lene Buhl Riis. (2018) SMAD4 Protein Expression Is Downregulated in Ileal Epithelial Cells from Patients with Crohn’s Disease with Significant Inverse Correlation to Disease Activity. Gastroenterology Research and Practice 2018, pages 1-8.
Crossref
Crossref
Chao Chen, Murugavel Ponnusamy, Cuiyun Liu, Jinning Gao, Kun Wang & Peifeng Li. (2017) MicroRNA as a Therapeutic Target in Cardiac Remodeling. BioMed Research International 2017, pages 1-25.
Crossref
Crossref
Samantha Ling, Yei-Tsung Chen, Juan Wang, Arthur Richards & Oi Liew. (2017) Ankyrin Repeat Domain 1 Protein: A Functionally Pleiotropic Protein with Cardiac Biomarker Potential. International Journal of Molecular Sciences 18:7, pages 1362.
Crossref
Crossref
Ambra Vestri, Federica Pierucci, Alessia Frati, Lucia Monaco & Elisabetta Meacci. (2017) Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?. Frontiers in Pharmacology 8.
Crossref
Crossref
Jinning Gao, Wenhua Xu, Jianxun Wang, Kun Wang & Peifeng Li. (2017) The Role and Molecular Mechanism of Non-Coding RNAs in Pathological Cardiac Remodeling. International Journal of Molecular Sciences 18:3, pages 608.
Crossref
Crossref
S N Tereshchenko, I V Zhirov & A G Kochetov. (2016) Translational medicine in Russian cardiology: a new stage or repetition of the past?. Terapevticheskii arkhiv 88:9, pages 5-9.
Crossref
Crossref
Sarah-Jane Walton, Amy Lewis, Rosemary Jeffery, Hannah Thompson, Roger Feakins, Eleni Giannoulatou, Christopher Yau, James O. Lindsay, Susan K. Clark & Andrew Silver. (2016) Familial adenomatous patients with desmoid tumours show increased expression of miR-34a in serum and high levels in tumours. Oncoscience 3:5-6, pages 173-185.
Crossref
Crossref